Advanced Search
Your search returned 406 results
  • Nov 29, 2010
    Definitive Results from U.S. IDE Study Demonstrate Durable Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms

    MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant(R) Stent Graft System...

  • Nov 29, 2010
    International Revenue of $1.6 Billion Grew 6% on a Constant Currency Basis; 4% As Reported

    MINNEAPOLIS, Nov 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2011, which ended October 29, 2010. The company...

  • Nov 22, 2010

    MINNEAPOLIS & MOUNTAIN VIEW, Calif., Nov 22, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and privately-held Ardian, Inc. announced today that they have entered into a merger agreement...

  • Nov 15, 2010
    New Features Offer Clinical and Operational Efficiencies for EMS and Hospital Teams

    REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today it has received 510(k) clearance from the U.S. Food...

  • Nov 15, 2010
    Innovative applications will allow clinicians to interact with patient ECG data in new ways

    SAN ANTONIO & REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Innovative new mobile cardiac monitoring solutions are on the horizon. At the American Heart Association Scientific Sessions 2010,...

  • Oct 5, 2010

    MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced the launch of the new KYPHON(R) Express(TM) Curette for scraping or scoring bone in the spine, including...

  • Aug 24, 2010
    Updates Fiscal Year 2011 Revenue Outlook and EPS Guidance

    MINNEAPOLIS, Aug 24, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2011, which ended July 30, 2010. The company reported...

  • Aug 17, 2010
    Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business

    MEMPHIS, Tenn., Aug 17, 2010 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) and Osteotech, Inc., (NASDAQ: OSTE) today announced that the companies have signed a definitive agreement under which...

  • Jul 27, 2010
    New biologic bone graft product demonstrated superior fusion rates compared to current standard of care for complex fusion procedures of the lower spine in the pivotal clinical trial

    MINNEAPOLIS, Jul 27, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and...

  • Jul 2, 2010

    MINNEAPOLIS, Jul 02, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced the company's recent initiation of a field correction on...